Recent Publications from the lab

Reprogramming T cell-myeloid crosstalk overcomes immune resistance in colorectal cancer

Mestrallet G, Brown M, Vaninov N, Cho NW, Velazquez L, Ananthanarayanan A, Spitzer M, Vabret N, Cimen Bozkus, C Samstein RM, Bhardwaj, N (2026). Cell Rep Med..

Retroelements orchestrate gut tolerance

Rosenberg L, and Vabret N. (2025). Nat Rev Immunol.

Viral mimicry in cancer therapy

Rosenberg L, and Vabret N. (2025). Trends Cancer.

Repeats mimic pathogen-associated patterns across a vast evolutionary landscape

Šulc P, Di Gioacchino A, Solovyov A, Sun S, (...) Vabret N, LaCava J, De Carvalho DD, Monasson R, Cocco S, Greenbaum, BD. (2025). Cell Genomics.

Generation of Lipid Nanoparticle mRNA Vaccines and Evaluation of Antigen-Specific CD8+ T-Cell Responses.

Ward RW., Ananthanarayanan A., Bhardwaj N. and Vabret N. (2025). Methods Mol Biol.

T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteome.

Cimen Bozkus C, Brown M, Velazquez L, (…), Vabret N, Luksza M, Bhardwaj N. T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteome. (2025) iScience.

Coordinated macrophage and T cell interactions mediate response to checkpoint blockade in colorectal cancer

Mestrallet G. (…) Vabret N., Cimen Bozkus C., Samstein RM, Bhardwaj N. (2025). Preprint at bioRxiv.

Interferon response and epigenetic modulation by SMARCA4 mutations drive ovarian tumor immunogenicity

Brodeur MN, Dopeso H, Zhu Y, Longhini ALF, Gazzo A, Sun S, Koche R, Qu R, Rosenberg L, (…), Vabret N, Weigelt B, Zamarin D. (2024). Science Adv.

Cancer cells restrict immunogenicity of retrotransposon expression via distinct mechanisms

Sun S, You E, Hong J, Hoyos D (…) Vabret N, De Carvalho DD, Zenklusen D, LaCava J, Lowe SW, Ting DT, Lacobuzio-Donahue CA, Solovyov A, Greenbaum BD (2024). Immunity.

T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteome

Cimen Bozkus C, Brown M, Velazquez M, Thomas M, Wilson EA, (…) Chowell D, Vabret N, Luksza M, Bhardwaj N (2024) Preprint at bioRxiv.

Hematopoietic aging promotes cancer by fueling IL-1⍺–driven emergency myelopoiesis

Park MD, Le Berichel J, Hamon P, Wilk CM, Belabed M, Yatim N, Saffon A, Boumelha J, Falcomatà C, Tepper A, Hegde S, Mattiuz R, Soong BY, LaMarche NM, Rentzeperis F, Troncoso L, Halasz L, Hennequin C, Chin T, Chen EP, Reid AM, Su M, Reid Cahn A, Koekkoek LL, Venturini N, Wood-isenberg S, D’souza D, Chen R, Dawson T, Nie K, Chen Z, Kim-Schulze S, Casanova-Acebes M, Swirski FK, Downward J, Vabret N, Brown BD, Marron TU, Merad M. (2024) Science.

Online immunology education for a global world

Vabret N, Mateus-Tique J , Salmon H, Martin JC, Mateo V, Serrano S, Lemoine F, Chammas R, Merad M. (2024) Nat Rev Immunol

Online technologies for immunology education can facilitate global outreach, incorporate local expertise, promote inclusivity and mitigate environmental costs of international travel. The experience gained from ten years of Immunoschool demonstrates how an engaging format with active participation is crucial to achieving these goals.

Protocol for the development of mRNA lipid nanoparticle vaccines and analysis of immunization efficiency in mice

Karekar N, Reid Cahn A , Morla-Folch J, , Saffon A , Ward RW, Ananthanarayanan A, Teunissen A, Bhardwaj N, Vabret N. (2024) STAR Protoc.

Here, we present a protocol for the development of mRNA-loaded lipid nanoparticle (LNP) vaccines for target antigen sequences of interest. We describe key steps required to design and synthesize mRNA constructs, their LNP encapsulation, and mouse immunization. We then detail quality control assays to determine RNA purity, guidelines to measure RNA immunogenicity using in vitro reporter systems, and a technique to evaluate antigen-specific T cell responses following immunization.

Featured in 2024 STAR Protocols Editors Collection: an editors' pick of the most notable papers (Top 5%) published in 2024.

Alternative RNA splicing generates shared clonal neoantigens across different types of cancer

Brown M, Vabret N. (2024) Nat Rev Immunol

Preprint clubs: why it takes a village to do peer review

Richter FC, Gea-Mallorquí E, Mortha A, Ruffin N, Vabret N. (2023) Nature Index

A group of early-career researchers have harnessed cross-institutional journal clubs to assess and review immunology preprints.

The Preprint Club - A blueprint for community-based peer review

Richter FC, Gea-Mallorquí E, Mortha A, Ruffin N, Vabret N. (2023) EMBO reports

Cross-institutional journal clubs focused on preprints are a new approach to community-based peer review and allow ERCs to gain experience.

The Preprint Club - A cross-institutional, community-based approach to peer reviewing

Richter FC, Gea-Mallorquí E, Ruffin N, Vabret N. (2023) Preprint at bioRxiv

Dark genome, bright ideas: Recent approaches to harness transposable elements in immunotherapies

Reid Cahn A, Bhardwaj N, Vabret N. (2022) Cancer Cell

Transposable elements (TEs), which make up almost half of the human genome, often display altered expression in cancers. Here, we review recent progress in elucidating the role of TEs as mediators of immune responses in cancer and discuss how novel therapeutic strategies can harness TE immunogenicity for cancer immunotherapy.

Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1

Vabret N, Najburg V, Solovyov A, et al. (2022) iScience

Repeat elements amplify TLR signaling

O’Donnell T, Vabret N. (2022) Nat Rev Immunol

Highlight of Rookhuizen, D. C. et al. Induction of transposable element expression is central to innate sensing. Preprint at bioRxiv https://doi.org/10.1101/2021.09.10.457789 (2021)

Repeats Mimic Immunostimulatory Viral Features Across a Vast Evolutionary Landscape

Šulc P, Solovyov A, Marhon SA, Sun S, LaCava J, Abdel-Wahab O, Vabret N, De Carvalho DD, Monasson R, Cocco S, Greenbaum BD (2021) Preprint at bioRxiv

Highlights from a year in a pandemic

Merad M, Vabret N. (2021) J Exp Med

COVID-19 has emerged as one of the worst pandemics in recent history and has exposed the weaknesses of healthcare systems worldwide. Here, we reflect on the lessons learned from a year in a pandemic. We discuss the extraordinary scientific advances made in our understanding of a new disease, the failed and successful attempts to halt its progression, and the impact of the pandemic on the scientific discourse within the global community.

SARS-CoV-2: the many pros of targeting PLpro

McClain CB, Vabret N. (2020) Signal Transduct Target Ther.

Antibody responses to SARS-CoV-2 short-lived

Vabret N. (2020) Nat Rev Immunology

Preclinical data from SARS-CoV-2 mRNA vaccine

Vabret N. (2020) Nat Rev Immunology

Immunology of COVID-19: Current State of the Science

Vabret N, Britton GJ, Gruber C, Hegde S, Kim J, Kuksin M, Levantovsky R, Malle L, Moreira A, Park MD, Pia L, Risson E, Saffern M, Salomé B, Esai Selvan M, Spindler MP, Tan J, van der Heide V, Gregory JK, Alexandropoulos K, Bhardwaj N, Brown BD, Greenbaum B, Gümüş ZH, Homann D, Horowitz A, Kamphorst AO, Curotto de Lafaille MA, Mehandru S, Merad M, Samstein RM; Sinai Immunology Review Project. (2020) Immunity

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide, igniting an unprecedented effort from the scientific community to understand the biological underpinning of COVID19 pathophysiology. In this Review, we summarize the current state of knowledge of innate and adaptive immune responses elicited by SARS-CoV-2 infection and the immunological pathways that likely contribute to disease severity and death. We also discuss the rationale and clinical outcome of current therapeutic strategies as well as prospective clinical trials to prevent or treat SARS-CoV-2 infection.

Hydroxychloroquine: small effects in mild disease

Levantovsky R, Vabret N. (2020) Nat Rev Immunology

Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive Classes

Solovyov A, Vabret N, Arora KS, Snyder A, Funt SA, Bajorin DF, Rosenberg JE, Bhardwaj N, Ting DT, Greenbaum BD. (2018) Cell Report

It has been posited that anti-tumoral innate activation is driven by derepression of endogenous repeats. We compared RNA sequencing protocols to assess repeat transcriptomes in The Cancer Genome Atlas (TCGA). Although poly(A) selection efficiently detects coding genes, most non-coding genes, and limited subsets of repeats, it fails to capture overall repeat expression and co-expression. Alternatively, total RNA expression reveals distinct repeat co-expression subgroups and delivers greater dynamic changes, implying they may serve as better biomarkers of clinical outcomes. We show that endogenous retrovirus expression predicts immunotherapy response better than conventional immune signatures in one cohort yet is not predictive in another. Moreover, we find that global repeat derepression, including the HSATII satellite repeat, correlates with an immunosuppressive phenotype in colorectal and pancreatic tumors and validate in situ. In conclusion, we stress the importance of analyzing the full spectrum of repeat transcription to decode their role in tumor immunity.

Sequence-Specific Sensing of Nucleic Acids

Vabret N, Bhardwaj N, Greenbaum BD. (2017) Trends Immunol

Innate immune cells are endowed with many nucleic acid receptors, but the role of sequence in the detection of foreign organisms remains unclear. Can sequence patterns influence recognition? In addition, how can we infer those patterns from sequence data? Here, we detail recent computational and experimental evidence associated with sequence-specific sensing. We review the mechanisms underlying the detection and discrimination of foreign sequences from self. We also describe quantitative approaches used to infer the stimulatory capacity of a given pathogen nucleic acid species, and the influence of sequence-specific sensing on host-pathogen coevolution, including endogenous sequences of foreign origin. Finally, we speculate how further studies of sequence-specific sensing will be useful to improve vaccine design, gene therapy and cancer treatment.

A full list of publications is accessible here